News...........

Saturday, September 6, 2008

Celestial Labs Ltd $$$$$

ROCKET STOCK.... CELESTIAL LABS LTD

TARGET 125/-

CELESTIAL LABS LTD Trading in BSE & NSE at 40/- in B Group. Target 75/- for short term & 125/- for Long Term. Safe Investment at 40/-.Market is stabilizing between 14,000 to 16,000; Crude also stabilizing. Inflation numbers also coming down. Right time to Enter Good Fundamental Stocks.CELESTIAL LABS Ltd at Rs.40/- is with Good Net Profit With EPS 12/- for 2008-09. First Quarter Net profit was 2.724 Crores. Equity 11 Crores, Company Projected EPS for 2008-09 is 12/- with Net Profit 13 Crores. As per This PE only 3.5. Normally PharmaCompanies PE will be minimum 10. If we take PE 10 It will come 120/-Good Dividend Paying Company; For 2007 – 2008 year 10% Dividend Declared.The company has declared its 1st Quarter results for 2008-2009. Net Sales at 5.2 Crores, Net profit at 2.724 Crores. EPS of 1st Quarter was 2.43 (Annual EPS 9.8/-). And Company Projections of 2008-2009 Sales at 27 crores and NetProfit at 13 Crores. The Projection Annualized Earning Per Share (EPS) at Rs 12/- for 2008 -2009 year. Expansion profits will coming to Next Quarters.For 2007 – 2008 year Sales at 19.9 crores and Net profit at 9.4 Crores EPS at 8.4/-. This year 2008 -2009 projection EPS is 12/- Net Profit 13 Crores.CELESTIAL LABS Ltd , Trading in BSE & NSE Celestial engaged in Drug Discovery, CRM (Contract Research & Manufacturing), Industrial Enzymes manufacturing, & IT division in ERP implementations, Bio Informatics. Now Its available very cheep price at 40/- Companred to Company growth and profits. Based on this Daily grabbing with Mumbai BIG BIG Bulls, and A LOT OF FII interest is seen in celestial because of Now stock is available at very very cheep price at 40/- EPS 12/- expecting for this Annual financial, with PE 3.5 only. and Company Growth. Normally in worst condition also PE will at 8. But Now PE is only 3.5. Fundamental is very very good. Total Equity of 11 Crores . Promoters Holding 37.54%; Private Corporate Bodies 8%; NRI’s 2.5%; Public 52%.Book Value of this Share was Rs. 51/-Company website : http://www.celestiallabs.com

Lot of acquisition is going on….So Don’t short this share. Celestial Labs has been supporting Pharma, Bio-pharma and Biotech manufacturing with customized ITsolutions and contract research. CLL also involved in the R&D, commercial production and marketing of enzymes, nutraceuticals.Celestial Labs is setting up a biotechnology facility in Genome Valley at Hyderabad, India to manufacture its own drug molecules, industrial enzymes and to contract research activities.The business plan of Celestial Labs is essentially based on the production and supply of the biotechnological products which have very significant industrial implications, especially in both Pharma and Bio-pharmaceutical sectors. The plan is envisaged after a thorough ground-work in terms of building up of a technology base through stake holders and collaborators, further supported by market analysis and import-export imperatives.Celestial Labs Ltd has acquired the channel partnership of Microsoft to strengthen Celestial ERP business. The main promoter of the Company, Dr. A N Singh is in the process transferring IPR rights worth total 11 crore as valued to the Company. However, Dr. A N Singh entitlement is 8.175 crore out of which he shall claim worth Rs 2.5 Crore shares not exceeding 5% on expended capital, balance will be subsequently claimed.This exercise shall immensely help the Company to increase the business in the smaller and medium sectors of ERP business.Celestial Labs Ltd has acquired the contract Research of Rational Laboratories located at Nacharam, Hyderabad and Sandiego, USA. As a part of the agreement Celestial Labs acquires laboratory space of around 48000 sq.feet which substantially enhances the Celestial Labs pitch in Contract Research and Drug Discovery business. Just Buy at 40/- Hold 1 to 6 months time. One may get minimum 100% to 200% returns.

No comments:

Disclaimer :


Disclaimer : This is only my views and not firm news and therefore I am not responsible for any kind of damaged or loss to viewer's property of funds. They can take their own decision for buying the stock/s at their own risk.
Powered By Blogger

GET PDF DOCUMENT..